Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study

MLA

Hideaki Ota, et al. “Clinical Impact of PCSK9 Inhibitor on Stabilization and Regression of Lipid-Rich Coronary Plaques: A near-Infrared Spectroscopy Study.” European Heart Journal. Cardiovascular Imaging, vol. 23, no. 2, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e56a341ec5e30917a9ed011f637aae67&authtype=sso&custid=ns315887.

APA

Hideaki Ota, Hiroyuki Omori, Hitoshi Matsuo, Akihiro Hirakawa, & Masanori Kawasaki. (2020). Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study. European Heart Journal. Cardiovascular Imaging, 23(2).

Chicago

Hideaki Ota, Hiroyuki Omori, Hitoshi Matsuo, Akihiro Hirakawa, and Masanori Kawasaki. 2020. “Clinical Impact of PCSK9 Inhibitor on Stabilization and Regression of Lipid-Rich Coronary Plaques: A near-Infrared Spectroscopy Study.” European Heart Journal. Cardiovascular Imaging 23 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e56a341ec5e30917a9ed011f637aae67&authtype=sso&custid=ns315887.